Researchers are testing whether a new, more personalised way of managing asthma can keep people’s symptoms under good control, so that they don’t need to use corticosteroid tablets (e.g., prednisone) so often.
Why is the research being done?
This research is an important step in designing a future where people living with asthma have good treatment options with less exposure to corticosteroids.
The approach being tested in this study – ‘Treatable Traits’
Professor Vanessa McDonald and her team are leading this research.
They are working to find out whether a new, personalised approach to treating asthma reduces the amount of corticosteroid tablets people need over a 1-year period.
Who can participate in the research trial?
This study is suitable for you if you have asthma, are aged 18 years or older and have taken corticosteroid tablets in the past 24 months.
What will study participants be asked to do? What does the study involve?
Key information:
- Around 300 people will take part in this trial.
- The trial goes for 1 year.
- Every person in the trial has a comprehensive assessment with the research team and has active asthma treatment.
- A participant summary will be given to you at the end of the study.
- If you take part, you will be randomly allocated to one of two groups. Group 1 will receive a recommendation for management as per asthma guidelines. Group 2 will receive the treatable traits approach.
- Across the year, there are a maximum of 7 in-person appointments, either at the John Hunter Hospital or the Hunter Medical Research Institute.
- Additionally, there are a maximum of 6 phone calls with a researcher.
How to participate
Download and read the Participant Information Sheet/Consent Form here
Contact the Clinical Trials Coordinator Amber Smith to discuss whether this research is right for you.
Amber Smith
T: +61 2 40420134
E: [email protected]
